Author (year) | Sex | Age | Size (cm) | Surgery | Adjuvant therapy | Margin | Prognosis | |
---|---|---|---|---|---|---|---|---|
1 | Fine G (1956) [18] | M | 39 | – | Y | – | – | Dead (55 days postoperatively) |
2 | Shirazi P H (1973) [19] | F | 56 | – | Y | N | – | Dead |
3 | Choudur HN (2005) [3] | M | 45 | 15 | Y | Doxorubicin cisplatin | – | Alive |
4 | Heukamp LC (2007) [13] | M | 61 | 20 | Y | Doxorubicin cisplatin cyclophosphamide ifosfamide | – | Dead (10 months postoperatively) |
5 | Lee KH (2007) [14] | M | 67 | 18 | Y | Ifosfamide adriamycin | – | Dead (4 months postoperatively) |
6 | Hussain MI (2011) [20] | M | 40 | 13 | Y | – | – | – |
7 | Oh SJ (2017) [21] | F | 70 | 15 | Y | N | – | Dead (2 months after discharge) |
8 | Van den Broek (2018) [7] | F | 71 | 14 | Y | N | – | Alive (peritoneal metastasis 5 months postoperatively) |
9 | Ito S (2018) [22] | F | 46 | 3.8 | Y | N | – | Alive (10 months postoperatively) |
10 | Our case (2021) | F | 75 | 11.5 | Y | N | Negative | Alive (9 months postoperatively) |